The ceramide transporter and the Goodpasture antigen binding protein: One protein - One function?

Journal of Neurochemistry

Volumn 113, Issue 6, 2010, Pages 1369-1386

  Mencarelli, Chiara ^a   Losen, Mario ^a   Hammels, Caroline ^a   De Vry, Jochen ^a   Hesselink, Matthijs K C ^a   Steinbusch, Harry W M ^a   De Baets, Marc H ^a,b   Martínez Martínez, Pilar ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Autoimmunity; Ceramide; GPBP CERT; Neurodegenerative diseases

Indexed keywords

AMINO ACID TRANSPORTER; AMYLOID BETA PROTEIN; BINDING PROTEIN; CERAMIDE; CERAMIDE TRANSPORTER; COLLAGEN BINDING PROTEIN; COLLAGEN TYPE 4; GOODPASTURE ANTIGEN BINDING PROTEIN; MITOCHONDRIAL CREATINE KINASE; NERVE GROWTH FACTOR; OXYSTEROL; PHOSPHOLIPASE C; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; APOPTOSIS; AUTOIMMUNITY; BRAIN CELL; BRAIN DEVELOPMENT; CELL AGING; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CHO CELL; DEGENERATIVE DISEASE; DNA DAMAGE; ENDOPLASMIC RETICULUM; FARBER DISEASE; GAUCHER DISEASE; GENE MUTATION; GENETIC TRANSCRIPTION; GLOBOID CELL LEUKODYSTROPHY; GOLGI COMPLEX; GOODPASTURE SYNDROME; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; LIPID TRANSPORT; LIPOGENESIS; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; RNA INTERFERENCE; RNA SPLICING; RNA TRANSLATION; TRANSLATION INITIATION; ZEBRA FISH;

ANIMALS; AUTOANTIGENS; CENTRAL NERVOUS SYSTEM; COLLAGEN TYPE IV; HUMANS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PROTEIN SPLICING; PROTEIN-SERINE-THREONINE KINASES;

DANIO RERIO; MUS;

EID: 77953105779     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06673.x     Document Type: Review

References (172)

1. Aharon-Peretz J., Rosenbaum H. Gershoni-Baruch R. (2004) Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 351, 1972 1977.
2. Alpy F. Tomasetto C. (2005) Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J. Cell Sci. 118, 2791 2801.
3. Ardail D., Popa I., Alcantara K., Pons A., Zanetta J. P., Louisot P., Thomas L. Portoukalian J. (2001) Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria. FEBS Lett. 488, 160 164.
4. Arnoult D., Grodet A., Lee Y. J., Estaquier J. Blackstone C. (2005) Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J. Biol. Chem. 280, 35742 35750.
5. Ayasolla K., Khan M., Singh A. K. Singh I. (2004) Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic. Biol. Med. 37, 325 338.
6. Bar J., Linke T., Ferlinz K., Neumann U., Schuchman E. H. Sandhoff K. (2001) Molecular analysis of acid ceramidase deficiency in patients with Farber disease. Hum. Mutat. 17, 199 209.
7. Baron G. S., Wehrly K., Dorward D. W., Chesebro B. Caughey B. (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J. 21, 1031 1040.
8. Bieberich E., MacKinnon S., Silva J. Yu R. K. (2001) Regulation of apoptosis during neuronal differentiation by ceramide and b-series complex gangliosides. J. Biol. Chem. 276, 44396 44404.
9. Bionda C., Portoukalian J., Schmitt D., Rodriguez-Lafrasse C. Ardail D. (2004) Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? Biochem. J. 382, 527 533.
10. Birbes H., Luberto C., Hsu Y. T., El Bawab S., Hannun Y. A. Obeid L. M. (2005) A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. Biochem. J. 386, 445 451.
11. Blanchette-Mackie E. J., Dwyer N. K., Amende L. M. et al. (1988) Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc. Natl Acad. Sci. USA 85, 8022 8026.
12. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y. Hirsch E. C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172, 151 154.
13. Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z. Kolesnick R. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405 414.
14. Brady R. O., Kanfer J. N. Shapiro D. (1965) Metabolism of glucocerebrosides. I. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem. Biophys. Res. Commun. 18, 221 225.
15. Brady R. O., Kanfer J. N., Mock M. B. Fredrickson D. S. (1966) The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc. Natl Acad. Sci. USA 55, 366 369.
16. Brann A. B., Scott R., Neuberger Y., Abulafia D., Boldin S., Fainzilber M. Futerman A. H. (1999) Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J. Neurosci. 19, 8199 8206.
17. Brann A. B., Tcherpakov M., Williams I. M., Futerman A. H. Fainzilber M. (2002) Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. 277, 9812 9818.
18. Bras J., Singleton A., Cookson M. R. Hardy J. (2008) Emerging pathways in genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease. FEBS J. 275, 5767 5773.
19. Bras J., Paisan-Ruiz C., Guerreiro R., Ribeiro M. H., Morgadinho A., Januario C., Sidransky E., Oliveira C. Singleton A. (2009) Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol. Aging 30, 1515 1517.
20. Brugg B., Michel P. P., Agid Y. Ruberg M. (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66, 733 739.
21. Brugger B., Sandhoff R., Wegehingel S., Gorgas K., Malsam J., Helms J. B., Lehmann W. D., Nickel W. Wieland F. T. (2000) Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles. J. Cell Biol. 151, 507 518.
22. Buccoliero R. Futerman A. H. (2003) The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol. Res. 47, 409 419.
23. Chamberlain L. H., Burgoyne R. D. Gould G. W. (2001) SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc. Natl Acad. Sci. USA 98, 5619 5624.
24. Chen S. J., Ko C. Y., Yen C. W. Wang C. C. (2009) Translational efficiency of redundant ACG initiator codons is enhanced by a favorable sequence context and remedial initiation. J. Biol. Chem. 284, 818 827.
25. Cheng X. P., Wang B. R., Liu H. L., You S. W., Huang W. J., Jiao X. Y. Ju G. (2003) Phosphorylation of extracellular signal-regulated kinases 1/2 is predominantly enhanced in the microglia of the rat spinal cord following dorsal root transection. Neuroscience 119, 701 712.
26. Choi D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261 1276.
27. Cutler R. G. Mattson M. P. (2001) Sphingomyelin and ceramide as regulators of development and lifespan. Mech. Ageing Dev. 122, 895 908.
28. Cutler R. G., Kelly J., Storie K., Pedersen W. A., Tammara A., Hatanpaa K., Troncoso J. C. Mattson M. P. (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 2070 2075.
29. D'Angelo G., Polishchuk E., Di Tullio G. et al. (2007) Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 449, 62 67.
30. Dobrowsky R. T., Werner M. H., Castellino A. M., Chao M. V. Hannun Y. A. (1994) Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265, 1596 1599.
31. van Echten-Deckert G. Herget T. (2006) Sphingolipid metabolism in neural cells. Biochim. Biophys. Acta 1758, 1978 1994.
32. El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J. J. Hannun Y. A. (2000) Molecular cloning and characterization of a human mitochondrial ceramidase. J. Biol. Chem. 275, 21508 21513.
33. Faili A., Aoufouchi S., Weller S., Vuillier F., Stary A., Sarasin A., Reynaud C. A. Weill J. C. (2004) DNA polymerase eta is involved in hypermutation occurring during immunoglobulin class switch recombination. J. Exp. Med. 199, 265 270.
34. Fukasawa M., Nishijima M. Hanada K. (1999) Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J. Cell Biol. 144, 673 685.
35. Funakoshi T., Yasuda S., Fukasawa M., Nishijima M. Hanada K. (2000) Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J. Biol. Chem. 275, 29938 29945.
36. Furuya S., Mitoma J., Makino A. Hirabayashi Y. (1998) Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. J. Neurochem. 71, 366 377.
37. Futerman A. H. van Meer G. (2004) The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5, 554 565.
38. Gatt S., Barenholz Y. Roitman A. (1966) Isolation of rat brain lecithinase-A, specific for the alpha'-position of lecithin. Biochem. Biophys. Res. Commun. 24, 169 172.
39. Ghafourifar P., Klein S. D., Schucht O., Schenk U., Pruschy M., Rocha S. Richter C. (1999) Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. J. Biol. Chem. 274, 6080 6084.
40. Godi A., Di Campli A., Konstantakopoulos A., Di Tullio G., Alessi D. R., Kular G. S., Daniele T., Marra P., Lucocq J. M. De Matteis M. A. (2004) FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat. Cell Biol. 6, 393 404.
41. Goni F. M. Alonso A. (2006) Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta 1758, 1902 1921.
42. Granero F., Revert F., Revert-Ros F., Lainez S., Martinez-Martinez P. Saus J. (2005) A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein. FEBS J. 272, 5291 5305.
43. Granero-Molto F., Sarmah S., O'Rear L., Spagnoli A., Abrahamson D., Saus J., Hudson B. G. Knapik E. W. (2008) Goodpasture antigen-binding protein and its spliced variant, ceramide transfer protein, have different functions in the modulation of apoptosis during zebrafish development. J. Biol. Chem. 283 (29 20495 20504.
44. Gross A., Jockel J., Wei M. C. Korsmeyer S. J. (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878 3885.
45. Gudz T. I., Tserng K. Y. Hoppel C. L. (1997) Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J. Biol. Chem. 272, 24154 24158.
46. Gulbins E., Bissonnette R., Mahboubi A. et al. (1995) FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2, 341 351.
47. Haimovitz-Friedman A., Kolesnick R. N. Fuks Z. (1997) Ceramide signaling in apoptosis. Br. Med. Bull. 53, 539 553.
48. van Ham T. J., Thijssen K. L., Breitling R., Hofstra R. M., Plasterk R. H. Nollen E. A. (2008) C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4, e1000027.
49. Hanada K., Kumagai K., Yasuda S., Miura Y., Kawano M., Fukasawa M. Nishijima M. (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426, 803 809.
50. Hanada K., Kumagai K., Tomishige N. Kawano M. (2007) CERT and intracellular trafficking of ceramide. Biochim. Biophys. Acta 1771, 644 653.
51. Hannun Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855 1859.
52. Hannun Y. A. Luberto C. (2000) Ceramide in the eukaryotic stress response. Trends Cell Biol. 10, 73 80.
53. Hannun Y. A. Obeid L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73 77.
54. Hannun Y. A. Obeid L. M. (2002) The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277, 25847 25850.
55. Huang Y., Tanimukai H., Liu F., Iqbal K., Grundke-Iqbal I. Gong C. X. (2004) Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain. Eur. J. Neurosci. 20, 3489 3497.
56. Huitema K., van den Dikkenberg J., Brouwers J. F. Holthuis J. C. (2004) Identification of a family of animal sphingomyelin synthases. EMBO J. 23, 33 44.
57. Huwiler A., Kolter T., Pfeilschifter J. Sandhoff K. (2000) Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485, 63 99.
58. Ichikawa S., Sakiyama H., Suzuki G., Hidari K. I. Hirabayashi Y. (1996) Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl Acad. Sci. USA 93, 4638 4643.
59. Irie F. Hirabayashi Y. (1998) Application of exogenous ceramide to cultured rat spinal motoneurons promotes survival or death by regulation of apoptosis depending on its concentrations. J. Neurosci. Res. 54, 475 485.
60. Jana A. Pahan K. (2004) Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J. Biol. Chem. 279, 51451 51459.
61. Jayadev S. Hannun Y. A. (1996) Ceramide: role in growth inhibitory cascades. J. Lipid Mediat. Cell Signal. 14, 295 301.
62. Jayadev S., Liu B., Bielawska A. E., Lee J. Y., Nazaire F., Pushkareva M., Obeid L. M. Hannun Y. A. (1995) Role for ceramide in cell cycle arrest. J. Biol. Chem. 270, 2047 2052.
63. Jeyakumar M., Butters T. D., Dwek R. A. Platt F. M. (2002) Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathol. Appl. Neurobiol. 28, 343 357.
64. Kann O. Kovacs R. (2007) Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol. 292, C641 C657.
65. Kawano M., Kumagai K., Nishijima M. Hanada K. (2006) Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J. Biol. Chem. 281, 30279 30288.
66. Kivipelto M., Helkala E. L., Laakso M. P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J. Nissinen A. (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322, 1447 1451.
67. Kolesnick R. Hannun Y. A. (1999) Ceramide and apoptosis. Trends Biochem. Sci. 24, 224 225 author reply 227.
68. Kolesnick R. N. Kronke M. (1998) Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643 665.
69. Kolesnick R. N., Goni F. M. Alonso A. (2000) Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol. 184, 285 300.
70. Kronke M. (1999) Involvement of sphingomyelinases in TNF signaling pathways. Chem. Phys. Lipids 102, 157 166.
71. Kumagai K., Yasuda S., Okemoto K., Nishijima M., Kobayashi S. Hanada K. (2005) CERT mediates intermembrane transfer of various molecular species of ceramides. J. Biol. Chem. 280, 6488 6495.
72. Kumagai K., Kawano M., Shinkai-Ouchi F., Nishijima M. Hanada K. (2007) Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT. J. Biol. Chem. 282, 17758 17766.
73. Lagace T. A., Byers D. M., Cook H. W. Ridgway N. D. (1997) Altered regulation of cholesterol and cholesteryl ester synthesis in Chinese-hamster ovary cells overexpressing the oxysterol-binding protein is dependent on the pleckstrin homology domain. Biochem. J. 326 (Pt 1 205 213.
74. Lagace T. A., Byers D. M., Cook H. W. Ridgway N. D. (1999) Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol. J. Lipid Res. 40, 109 116.
75. Laitinen S., Olkkonen V. M., Ehnholm C. Ikonen E. (1999) Family of human oxysterol binding protein (OSBP) homologues. A novel member implicated in brain sterol metabolism. J. Lipid Res. 40, 2204 2211.
76. Ledesma M. D., Brugger B., Bunning C., Wieland F. T. Dotti C. G. (1999) Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes. EMBO J. 18, 1761 1771.
77. Lee J. T., Xu J., Lee J. M., Ku G., Han X., Yang D. I., Chen S. Hsu C. Y. (2004) Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123 131.
78. Lehto M. Olkkonen V. M. (2003) The OSBP-related proteins: a novel protein family involved in vesicle transport, cellular lipid metabolism, and cell signalling. Biochim. Biophys. Acta 1631, 1 11.
79. Lehto M., Laitinen S., Chinetti G., Johansson M., Ehnholm C., Staels B., Ikonen E. Olkkonen V. M. (2001) The OSBP-related protein family in humans. J. Lipid Res. 42, 1203 1213.
80. Levade T. Jaffrezou J. P. (1999) Signalling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta 1438, 1 17.
81. Levade T., Salvayre R. Douste-Blazy L. (1986) Sphingomyelinases and Niemann-Pick disease. J. Clin. Chem. Clin. Biochem. 24, 205 220.
82. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154 1162.
83. Levine T. P. Munro S. (2002) Targeting of Golgi-specific pleckstrin homology domains involves both PtdIns 4-kinase-dependent and -independent components. Curr. Biol. 12, 695 704.
84. Li C. M., Park J. H., He X. et al. (1999) The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 62, 223 231.
85. Lightle S. A., Oakley J. I. Nikolova-Karakashian M. N. (2000) Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech. Ageing Dev. 120, 111 125.
86. Liu P. Anderson R. G. (1995) Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270, 27179 27185.
87. Loewen C. J., Roy A. Levine T. P. (2003) A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. EMBO J. 22, 2025 2035.
88. Malaplate-Armand C., Florent-Bechard S., Youssef I., Koziel V., Sponne I., Kriem B., Leininger-Muller B., Olivier J. L., Oster T. Pillot T. (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol. Dis. 23, 178 189.
89. Mannella C. A. (2006) The relevance of mitochondrial membrane topology to mitochondrial function. Biochim. Biophys. Acta 1762, 140 147.
90. Manning-Bog A. B., Schule B. Langston J. W. (2009) Alpha-synuclein- glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. Neurotoxicology 30, 1127 1132.
91. Mao C., Xu R., Szulc Z. M., Bielawski J., Becker K. P., Bielawska A., Galadari S. H., Hu W. Obeid L. M. (2003) Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J. Biol. Chem. 278, 31184 31191.
92. Mata I. F., Samii A., Schneer S. H. et al. (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch. Neurol. 65, 379 382.
93. Mathias S., Pena L. A. Kolesnick R. N. (1998) Signal transduction of stress via ceramide. Biochem. J. 335 (Pt 3 465 480.
94. McCoy M. K. Tansey M. G. (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 5, 45.
95. van Meer G. Holthuis J. C. (2000) Sphingolipid transport in eukaryotic cells. Biochim. Biophys. Acta 1486, 145 170.
96. Meiron M., Anunu R., Scheinman E. J., Hashmueli S. Levi B. Z. (2001) New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5′UTR. Biochem. Biophys. Res. Commun. 282, 1053 1060.
97. Mencarelli C., Hammels C., Van Broeck Den J. et al. (2009) The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain. J. Chem. Neuroanat. 38, 97 105.
98. Merrill Jr. A. H., Schmelz E. M., Dillehay D. L., Spiegel S., Shayman J. A., Schroeder J. J., Riley R. T., Voss K. A. Wang E. (1997) Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142, 208 225.
99. Mielke M. M., Bandaru V. V., Haughey N. J., Rabins P. V., Lyketsos C. G. Carlson M. C. (2008) Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol. Aging 31 (1 17 24.
100. Mitoma J., Ito M., Furuya S. Hirabayashi Y. (1998) Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners. J. Neurosci. Res. 51, 712 722.
101. Mitoma J., Furuya S. Hirabayashi Y. (1999) A novel metabolic interaction between neurons and glial cells through L-serine: an essential role for astroglia-derived L-serine in the survival and development of CNS neurons. Seikagaku 71, 536 541.
102. Montes L. R., Ruiz-Arguello M. B., Goni F. M. Alonso A. (2002) Membrane restructuring via ceramide results in enhanced solute efflux. J. Biol. Chem. 277, 11788 11794.
103. Mouton R. E. Venable M. E. (2000) Ceramide induces expression of the senescence histochemical marker, beta-galactosidase, in human fibroblasts. Mech. Ageing Dev. 113, 169 181.
104. Nieto-Sampedro M. Nieto-Diaz M. (2005) Neural plasticity: changes with age. J. Neural Transm. 112, 3 27.
105. Obeid L. M., Linardic C. M., Karolak L. A. Hannun Y. A. (1993) Programmed cell death induced by ceramide. Science 259, 1769 1771.
106. Ohashi E., Bebenek K., Matsuda T., Feaver W. J., Gerlach V. L., Friedberg E. C., Ohmori H. Kunkel T. A. (2000) Fidelity and processivity of DNA synthesis by DNA polymerase kappa, the product of the human DINB1 gene. J. Biol. Chem. 275, 39678 39684.
107. Okazaki T., Kondo T., Kitano T. Tashima M. (1998) Diversity and complexity of ceramide signalling in apoptosis. Cell. Signal. 10, 685 692.
108. Olkkonen V. M., Johansson M., Suchanek M., Yan D., Hynynen R., Ehnholm C., Jauhiainen M., Thiele C. Lehto M. (2006) The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes? Biochem. Soc. Trans. 34, 389 391.
109. Otterbach B. Stoffel W. (1995) Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81, 1053 1061.
110. Palestini P., Masserini M., Fiorilli A., Calappi E. Tettamanti G. (1993) Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin. J. Neurochem. 61, 955 960.
111. Pandey S., Murphy R. F. Agrawal D. K. (2007) Recent advances in the immunobiology of ceramide. Exp. Mol. Pathol. 82, 298 309.
112. Pastores G. M. (2009) Krabbe disease: an overview. Int. J. Clin. Pharmacol. Ther. 47 (Suppl 1 S75 S81.
113. Paumard P., Vaillier J., Coulary B., Schaeffer J., Soubannier V., Mueller D. M., Brethes D., di Rago J. P. Velours J. (2002) The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J. 21, 221 230.
114. Pelled D., Trajkovic-Bodennec S., Lloyd-Evans E., Sidransky E., Schiffmann R. Futerman A. H. (2005) Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol. Dis. 18, 83 88.
115. Perry D. K. Hannun Y. A. (1998) The role of ceramide in cell signaling. Biochim. Biophys. Acta 1436, 233 243.
116. Perry R. J. Ridgway N. D. (2006) Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol. Biol. Cell 17, 2604 2616.
117. Pettus B. J., Chalfant C. E. Hannun Y. A. (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585, 114 125.
118. Prats H., Kaghad M., Prats A. C. et al. (1989) High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl Acad. Sci. USA 86, 1836 1840.
119. Prinetti A., Chigorno V., Prioni S., Loberto N., Marano N., Tettamanti G. Sonnino S. (2001) Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J. Biol. Chem. 276, 21136 21145.
120. Radin N. S. (2003) Infections and glycolipids. Postgrad. Med. J. 79, 185.
121. Rajendran L. Simons K. (2005) Lipid rafts and membrane dynamics. J. Cell Sci. 118, 1099 1102.
122. Rajendran L., Honsho M., Zahn T. R., Keller P., Geiger K. D., Verkade P. Simons K. (2006) Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl Acad. Sci. USA 103, 11172 11177.
123. Rao R. P., Yuan C., Allegood J. C., Rawat S. S., Edwards M. B., Wang X., Merrill Jr. A. H., Acharya U. Acharya J. K. (2007) Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc. Natl Acad. Sci. USA 104, 11364 11369.
124. Raya A., Revert F., Navarro S. Saus J. (1999) Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen. J. Biol. Chem. 274, 12642 12649.
125. Raya A., Revert-Ros F., Martinez-Martinez P., Navarro S., Rosello E., Vieites B., Granero F., Forteza J. Saus J. (2000) Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J. Biol. Chem. 275, 40392 40399.
126. Revert F., Merino R., Monteagudo C. et al. (2007) Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane. Am. J. Pathol. 171, 1419 1430.
127. Revert F., Ventura I., Martinez-Martinez P., Granero-Molto F., Revert-Ros F., Macias J. Saus J. (2008) Goodpasture antigen-binding protein is a soluble exportable protein that interacts with type IV collagen. Identification of novel membrane-bound isoforms. J. Biol. Chem. 283, 30246 30255.
128. Riboni L., Prinetti A., Bassi R., Caminiti A. Tettamanti G. (1995) A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J. Biol. Chem. 270, 26868 26875.
129. Ridgway N. D., Dawson P. A., Ho Y. K., Brown M. S. Goldstein J. L. (1992) Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. J. Cell Biol. 116, 307 319.
130. Rodriguez-Lafrasse C., Alphonse G., Broquet P., Aloy M. T., Louisot P. Rousson R. (2001) Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis. Biochem. J. 357, 407 416.
131. Salama A. D., Levy J. B., Lightstone L. Pusey C. D. (2001) Goodpasture's disease. Lancet 358, 917 920.
132. Satoi H., Tomimoto H., Ohtani R. et al. (2005) Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Neuroscience 130, 657 666.
133. Schwarz A. Futerman A. H. (1997) Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J. Neurosci. 17, 2929 2938.
134. Schweizer A., Clausen H., van Meer G. Hauri H. P. (1994) Localization of O-glycan initiation, sphingomyelin synthesis, and glucosylceramide synthesis in Vero cells with respect to the endoplasmic reticulum-Golgi intermediate compartment. J. Biol. Chem. 269, 4035 4041.
135. Scorrano L., Ashiya M., Buttle K., Weiler S., Oakes S. A., Mannella C. A. Korsmeyer S. J. (2002) A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2, 55 67.
136. Shimeno H., Soeda S., Sakamoto M., Kouchi T., Kowakame T. Kihara T. (1998) Partial purification and characterization of sphingosine N-acyltransferase (ceramide synthase) from bovine liver mitochondrion-rich fraction. Lipids 33, 601 605.
137. Sidransky E., Nalls M. A., Aasly J. O. et al. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651 1661.
138. Simons K. Ehehalt R. (2002) Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110, 597 603.
139. Simons K. Vaz W. L. (2004) Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33, 269 295.
140. Simons M., Keller P., Dichgans J. Schulz J. B. (2001) Cholesterol and Alzheimer's disease: is there a link? Neurology 57, 1089 1093.
141. Siskind L. J. (2005) Mitochondrial ceramide and the induction of apoptosis. J. Bioenerg. Biomembr. 37, 143 153.
142. Siskind L. J. Colombini M. (2000) The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 275, 38640 38644.
143. Small D. M. (1970) Surface and bulk interactions of lipids and water with a classification of biologically active lipids based on these interactions. Fed. Proc. 29, 1320 1326.
144. Sot J., Goni F. M. Alonso A. (2005) Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides. Biochim. Biophys. Acta 1711, 12 19.
145. Spence M. W. Burgess J. K. (1978) Acid and neutral sphingomyelinases of rat brain. Activity in developing brain and regional distribution in adult brain. J. Neurochem. 30, 917 919.
146. Spiegel S. Merrill Jr. A. H. (1996) Sphingolipid metabolism and cell growth regulation. FASEB J. 10, 1388 1397.
147. Suzuki T. (2002) Lipid rafts at postsynaptic sites: distribution, function and linkage to postsynaptic density. Neurosci. Res. 44, 1 9.
148. Tang H. L., Yeh L. S., Chen N. K., Ripmaster T., Schimmel P. Wang C. C. (2004) Translation of a yeast mitochondrial tRNA synthetase initiated at redundant non-AUG codons. J. Biol. Chem. 279, 49656 49663.
149. Tani M., Igarashi Y. Ito M. (2005) Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu. J. Biol. Chem. 280, 36592 36600.
150. Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L. Prusiner S. B. (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129, 121 132.
151. Tepper A. D., de Vries E., van Blitterswijk W. J. Borst J. (1999) Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J. Clin. Invest. 103, 971 978.
152. Thomas Jr. R. L., Matsko C. M., Lotze M. T. Amoscato A. A. (1999) Mass spectrometric identification of increased C16 ceramide levels during apoptosis. J. Biol. Chem. 274, 30580 30588.
153. Toman R. E., Spiegel S. Faden A. I. (2000) Role of ceramide in neuronal cell death and differentiation. J. Neurotrauma 17, 891 898.
154. Touriol C., Bornes S., Bonnal S., Audigier S., Prats H., Prats A. C. Vagner S. (2003) Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons. Biol. Cell 95, 169 178.
155. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., Schwille P., Brugger B. Simons M. (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244 1247. (Pubitemid 351323020)
156. Tsujishita Y. Hurley J. H. (2000) Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Biol. 7, 408 414.
157. Veiga M. P., Arrondo J. L., Goni F. M. Alonso A. (1999) Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys. J. 76, 342 350.
158. Venable M. E., Lee J. Y., Smyth M. J., Bielawska A. Obeid L. M. (1995) Role of ceramide in cellular senescence. J. Biol. Chem. 270, 30701 30708.
159. Venkataraman K. Futerman A. H. (2000) Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol. 10, 408 412.
160. Verheij M., Bose R., Lin X. H. et al. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75 79.
161. Vetrivel K. S., Cheng H., Lin W., Sakurai T., Li T., Nukina N., Wong P. C., Xu H. Thinakaran G. (2004) Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279, 44945 44954.
162. Wang Y. M., Seibenhener M. L., Vandenplas M. L. Wooten M. W. (1999) Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival. J. Neurosci. Res. 55, 293 302.
163. Wang C. C., Chang K. J., Tang H. L., Hsieh C. J. Schimmel P. (2003) Mitochondrial form of a tRNA synthetase can be made bifunctional by manipulating its leader peptide. Biochemistry 42, 1646 1651.
164. Wang X., Rao R. P., Kosakowska-Cholody T. et al. (2009) Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J. Cell Biol. 184, 143 158.
165. Wyles J. P., McMaster C. R. Ridgway N. D. (2002) Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum. J. Biol. Chem. 277, 29908 29918.
166. Xu R., Jin J., Hu W., Sun W., Bielawski J., Szulc Z., Taha T., Obeid L. M. Mao C. (2006) Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P. FASEB J. 20, 1813 1825.
167. Yamaoka S., Miyaji M., Kitano T., Umehara H. Okazaki T. (2004) Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J. Biol. Chem. 279, 18688 18693.
168. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B. Kroemer G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367 377.
169. Zeng C., Lee J. T., Chen H., Chen S., Hsu C. Y. Xu J. (2005) Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. J. Neurochem. 94, 703 712.
170. Zerbinatti C. V., Cordy J. M., Chen C. D., Guillily M., Suon S., Ray W. J., Seabrook G. R., Abraham C. R. Wolozin B. (2008) Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein. Mol. Neurodegener. 3, 5.
171. Zhang Y., Yuan F., Wu X., Wang M., Rechkoblit O., Taylor J. S., Geacintov N. E. Wang Z. (2000) Error-free and error-prone lesion bypass by human DNA polymerase kappa in vitro. Nucleic Acids Res. 28, 4138 4146.
172. Zhang Y., Li X., Becker K. A. Gulbins E. (2009) Ceramide-enriched membrane domains-structure and function. Biochim. Biophys. Acta 1788, 178 183.